Dr. Danielle Marie Pineda, MD

Dr. Pineda practices at AtlantiCare Surgery Center, Egg Harbor Township in Egg Harbor Township, New Jersey.

Dr. Pineda's NPI, 1447417522, was assigned on May 17, 2008. Dr. Pineda holds New Jersey license 25MA12507000.

Dr. Pineda's primary practice is AtlantiCare Surgery Center, Egg Harbor Township, at 2500 English Creek Ave, Bldg700, Suite 702, Egg Harbor Township, NJ 08234. The practice phone is (609) 407-2276.

Dr. Pineda's primary practice is AtlantiCare Surgery Center, Egg Harbor Township in Egg Harbor Township, New Jersey. Dr. Pineda is also affiliated with AtlantiCare Regional Medical Center, Atlantic City Campus. The medical group on file is AtlantiCare Physician Group. Dmand AI also links Dr. Pineda to 4 more medical groups, 2 group practices and clinics and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pineda practices, 5 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Pineda's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dmand AI has Dr. Pineda's licenses on file in 2 states: New Jersey and Pennsylvania.

CMS data shows 1,419 Medicare services from Dr. Pineda across 20 procedure codes in 2024, for 751 Medicare patients. Medicare paid $139,972 for them.

CMS counts 751 Medicare patients who saw Dr. Pineda in 2024. The largest group is 75 to 84, with 332 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.19, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pineda's median patient age at 71, with 50% women.

In 2024, Dr. Pineda wrote 294 Medicare Part D claims for 90 patients. 79% of them were for generic drugs. CMS names the drug for 248 of them, across 5 drugs with 11 or more claims each, at $55,413 in total drug cost. In 2023, CMS named 190 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Pineda for performance year 2024, reported as part of a group. Dr. Pineda accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Pineda as offering telehealth. CMS counts 23 procedures of leg revascularization (restoring blood flow) by Dr. Pineda, more than 83% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 24 papers to Dr. Pineda, published from 2012 to 2025. 2016 was the busiest year, with 4. The most frequent topics are Endovascular Procedures, Pancreatic Neoplasms and Stents. Dr. Pineda has published most often in Vasc Endovascular Surg. Dr. Pineda's most frequent co-authors are Keith Don Calligaro, MD, Matthew Joseph Dougherty and Douglas Troutman, DO.

Dmand AI links Dr. Pineda to 1 clinical trial. Conditions studied include Seroma and Surgical Wound Infection.

CMS Open Payments shows 473 general payments to Dr. Pineda from 49 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 63% of the total. Medtronic, Inc. paid the most, $82,461.